DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Propranolol for Treatment of Cocaine Addiction - 2

Information source: National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Cocaine-Related Disorders

Intervention: Propranolol (Drug)

Phase: Phase 2

Status: Completed

Sponsored by: National Institute on Drug Abuse (NIDA)

Official(s) and/or principal investigator(s):
Kyle Kampman, M.D., Principal Investigator, Affiliation: University of Pennsylvania


The purpose of this study is to evaluate the safety and efficacy of propanolol in the early treatment of cocaine dependence.

Clinical Details

Official title: Propranolol for Treatment of Cocaine Addiction

Study design: Primary Purpose: Treatment

Primary outcome:

Side effects

Cocaine use

Cocaine withdrawal

Cocaine craving

Mood and anxiety

Clinical improvement


Minimum age: 25 Years. Maximum age: 49 Years. Gender(s): Both.


Please contact site for information.

Locations and Contacts

University of Pennsylvania, Philadelphia, Pennsylvania 19104 6178, United States
Additional Information

Starting date: January 1987
Last updated: February 3, 2010

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017